CHINA PHARMA HOLDINGS, INC. (CPHI) Total liabilities 2016–2025
CHINA PHARMA HOLDINGS, INC. (CPHI) total liabilities at each fiscal year-end, per SEC filings.
$8.3MFY2025 · since FY2016: $19.6M → $8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.3M | +15.7% |
| FY2024 | $7.1M | -20.8% |
| FY2023 | $9.0M | -33.2% |
| FY2022 | $13.5M | -18.9% |
| FY2021 | $16.6M | +26.8% |
| FY2020 | $13.1M | +0.9% |
| FY2019 | $13.0M | -14.4% |
| FY2018 | $15.2M | -10.1% |
| FY2017 | $16.9M | -13.9% |
| FY2016 | $19.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice